Argentarii LLC Makes New $753,000 Investment in HCA Healthcare, Inc. (NYSE:HCA)

Argentarii LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the 4th quarter, Holdings Channel.com reports. The firm purchased 2,509 shares of the company’s stock, valued at approximately $753,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Evergreen Private Wealth LLC raised its stake in shares of HCA Healthcare by 0.3% in the 4th quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company’s stock valued at $3,838,000 after purchasing an additional 35 shares during the period. First Horizon Advisors Inc. raised its stake in shares of HCA Healthcare by 2.4% in the 3rd quarter. First Horizon Advisors Inc. now owns 1,532 shares of the company’s stock valued at $623,000 after purchasing an additional 36 shares during the period. Mediolanum International Funds Ltd increased its position in shares of HCA Healthcare by 0.3% in the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock valued at $3,153,000 after acquiring an additional 36 shares during the last quarter. Hartford Funds Management Co LLC increased its position in shares of HCA Healthcare by 1.6% in the third quarter. Hartford Funds Management Co LLC now owns 2,469 shares of the company’s stock valued at $1,003,000 after acquiring an additional 39 shares during the last quarter. Finally, Prairie Wealth Advisors Inc. increased its position in shares of HCA Healthcare by 6.1% in the fourth quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company’s stock valued at $210,000 after acquiring an additional 40 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.60% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on HCA. KeyCorp lowered their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. Cantor Fitzgerald reissued an “overweight” rating and set a $405.00 price target on shares of HCA Healthcare in a research report on Monday, January 27th. Barclays lowered their price target on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research report on Monday, January 27th. JPMorgan Chase & Co. reissued a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a research report on Tuesday, December 17th. Finally, Truist Financial lowered their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Trading Up 2.6 %

Shares of HCA stock opened at $330.11 on Friday. The stock’s fifty day moving average price is $316.70 and its two-hundred day moving average price is $347.49. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The company has a market cap of $81.27 billion, a PE ratio of 15.03, a P/E/G ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period last year, the firm posted $5.90 earnings per share. Equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be paid a $0.72 dividend. The ex-dividend date is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a dividend yield of 0.87%. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.